Novel method facilitates study of oxidized lipids involved in neurodegenerative diseases

NOVEMBER 15, 2023byFAPESPGraphical abstract. Credit:Free Radical Biology and Medicine(2023). DOI: 10.1016/j.freeradbiomed.2023.08.019Lipids are a diversified class of biomolecules wi

Updated on: March 28,2024

Novel method facilitates study of oxidized lipids involved in neurodegenerative diseases

NOVEMBER 15, 2023byFAPESPGraphical abstract. Credit:Free Radical Biology and Medicine(2023). DOI: 10.1016/j.freeradbiomed.2023.08.019Lipids are a diversified class of biomolecules wi

Updated on:March 28,2024

Dementia deaths rise during the summer of COVID, leading to concern

by Laurie Archbald-Pannone,The ConversationCredit: Unsplash/CC0 Public DomainDeaths from dementia during the summer of 2020 are nearly20% higherthan the number of dementia-related de

Updated on: March 19,2024

Dementia deaths rise during the summer of COVID, leading to concern

by Laurie Archbald-Pannone,The ConversationCredit: Unsplash/CC0 Public DomainDeaths from dementia during the summer of 2020 are nearly20% higherthan the number of dementia-related de

Updated on:March 19,2024

Neuroscientists map how the brain transforms sensation into action

bySainsbury Wellcome CentreResearchers map how the brain transforms sensation into action. Credit: Sainsbury Wellcome CentreNeuroscientists have revealed how sensory input is transformed into mo

Updated on: September 23,2024

Neuroscientists map how the brain transforms sensation into action

bySainsbury Wellcome CentreResearchers map how the brain transforms sensation into action. Credit: Sainsbury Wellcome CentreNeuroscientists have revealed how sensory input is transformed into mo

Updated on:September 23,2024

Alzheimer's missing link ID'd, answering what tips brain's decline

by Washington University School of MedicineIn Alzheimer's, amyloid clumps (blue) develop first in the brain, followed by tangles of the protein tau (red). Tau is associated with memory loss a

Updated on: April 20,2024

Alzheimer's missing link ID'd, answering what tips brain's decline

by Washington University School of MedicineIn Alzheimer's, amyloid clumps (blue) develop first in the brain, followed by tangles of the protein tau (red). Tau is associated with memory loss a

Updated on:April 20,2024

FDA advisory panelist outlines issues with aducanumab's approval for Alzheimer's disease

by American College of PhysiciansPET scan of a human brain with Alzheimer's disease. Credit: public domainDespite near unanimous objection from its advisory panel, the U.S. Food and Drug Admi

Updated on: March 30,2024

FDA advisory panelist outlines issues with aducanumab's approval for Alzheimer's disease

by American College of PhysiciansPET scan of a human brain with Alzheimer's disease. Credit: public domainDespite near unanimous objection from its advisory panel, the U.S. Food and Drug Admi

Updated on:March 30,2024

Student-athletes with self-reported autism more likely to score low on common concussion test

by Saint Joseph's UniversityCredit: Pixabay/CC0 Public DomainSchools and colleges across the country rely on Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) evaluations to

Updated on: March 30,2024

Student-athletes with self-reported autism more likely to score low on common concussion test

by Saint Joseph's UniversityCredit: Pixabay/CC0 Public DomainSchools and colleges across the country rely on Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) evaluations to

Updated on:March 30,2024

Abnormal proteins found in the spinal fluid of people with ALS and frontotemporal dementia

byNational Institutes of HealthProtein containing a cryptic peptide (red) that results from a lack of functional TDP-43, as in ALS and FTD. Credit: NINDSResearchers at the National Institutes of

Updated on: March 13,2024

Abnormal proteins found in the spinal fluid of people with ALS and frontotemporal dementia

byNational Institutes of HealthProtein containing a cryptic peptide (red) that results from a lack of functional TDP-43, as in ALS and FTD. Credit: NINDSResearchers at the National Institutes of

Updated on:March 13,2024

Routine brain scanning may improve clinical care for people with psychosis

by University of OxfordCredit: AI-generated imageRoutine brain scanning in people experiencing psychosis could help to identify underlying physical conditions that are causing their symptoms, acc

Updated on: February 05,2024

Routine brain scanning may improve clinical care for people with psychosis

by University of OxfordCredit: AI-generated imageRoutine brain scanning in people experiencing psychosis could help to identify underlying physical conditions that are causing their symptoms, acc

Updated on:February 05,2024

Common degenerative brain disease may begin to develop already in middle age

byUniversity of HelsinkiImmunohistochemical staining with 5G4 antibody against alpha-synuclein in the Tampere Sudden Death Study cohort. Black arrowheads highlight LBs and gray arrowheads point

Updated on: March 28,2024

Common degenerative brain disease may begin to develop already in middle age

byUniversity of HelsinkiImmunohistochemical staining with 5G4 antibody against alpha-synuclein in the Tampere Sudden Death Study cohort. Black arrowheads highlight LBs and gray arrowheads point

Updated on:March 28,2024

Stool transplant shows promise for Parkinson's disease

by VIB (the Flanders Institute for Biotechnology)Credit: Pixabay/CC0 Public DomainParkinson's disease (PD) is a common neurodegenerative disease that affects millions worldwide. Now, a ground

Updated on: April 06,2024

Stool transplant shows promise for Parkinson's disease

by VIB (the Flanders Institute for Biotechnology)Credit: Pixabay/CC0 Public DomainParkinson's disease (PD) is a common neurodegenerative disease that affects millions worldwide. Now, a ground

Updated on:April 06,2024

Simple molecular reagents to treat Alzheimer's disease

by The Korea Advanced Institute of Science and Technology (KAIST)Overview of a rational strategy for designing compact aromatic molecules with multiple reactivities against pathological factors f

Updated on: June 20,2024

Simple molecular reagents to treat Alzheimer's disease

by The Korea Advanced Institute of Science and Technology (KAIST)Overview of a rational strategy for designing compact aromatic molecules with multiple reactivities against pathological factors f

Updated on:June 20,2024

A 'low dose aspirin' for dementia? Drug ready for first in-human testing

by University of KentuckyLinda Van Eldik in her lab at the Sanders-Brown Center on Aging. Van Eldik's drug candidate, which might function as a sort of "low-dose aspirin" for the pr

Updated on: March 13,2024

A 'low dose aspirin' for dementia? Drug ready for first in-human testing

by University of KentuckyLinda Van Eldik in her lab at the Sanders-Brown Center on Aging. Van Eldik's drug candidate, which might function as a sort of "low-dose aspirin" for the pr

Updated on:March 13,2024